Market Cap (In USD)
1.23 Billion
Revenue (In USD)
1.08 Billion
Net Income (In USD)
62.03 Million
Avg. Volume
2.04 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 13.39-42.08
- PE
- -
- EPS
- -
- Beta Value
- 1.44
- ISIN
- US74340E1038
- CUSIP
- 74340E103
- CIK
- 1551306
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Mr. Peter Anevski
- Employee Count
- -
- Website
- https://www.progyny.com
- Ipo Date
- 2019-10-25
- Details
- Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
More Stocks
-
HTHT
-
RCMNRCM Beteiligungs AG
RCMN
-
ROYALCU
-
MOD
-
VERUVeru Inc.
VERU
-
0046
-
TRKTrakcja S.A.
TRK
-
CPB